Brose, M. S., Worden, F. P., Newbold, K. L., Guo, M., & Hurria, A. Effect of age on the efficacy and safety of lenvatinib in radioiodine-refractory differentiated thyroid cancer in the phase III SELECT Trial. ABV-press.
Chicago Style (17th ed.) CitationBrose, M. S., F. P. Worden, K. L. Newbold, M. Guo, and A. Hurria. Effect of Age on the Efficacy and Safety of Lenvatinib in Radioiodine-refractory Differentiated Thyroid Cancer in the Phase III SELECT Trial. ABV-press.
MLA (9th ed.) CitationBrose, M. S., et al. Effect of Age on the Efficacy and Safety of Lenvatinib in Radioiodine-refractory Differentiated Thyroid Cancer in the Phase III SELECT Trial. ABV-press.
Warning: These citations may not always be 100% accurate.